Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
dmiller
Still waiting for you to post your brother-in-law,s legal opinion concerning the appellant brief by Singer and Amarin's chances of success...
SUPP...
Are you a lawyer or do you have legal expertise ????
RSU's
Your all pi**ing in the wind.... until you get the 400 institutional/ hedge funds to vote no with their 51% voting rights...All you guys are just moaning... find something else to do until court ruling
2 weeks till GENERIC BRIEFS:
I believe that the Generics will keep their APPELLANT BRIEF very simple and small... I believe that they will only acknowledge Judge Du's ruling in their brief .... Why give Singer more avenues to cite prior rulings and build Amarins case. They may take a posture not to let Singer's rebuttal further guide to CAFU to reverse Judge DU'S ruling. I would not expect much from their defense of the ruling at this point.... They already have what they want...
HinduKUSH,
Reviewing the 6 patents invalidated by Judge Du concerning Mori studies in her ruling....
Patent 8293728 ( 4 Mori citings in Patent )
1. year 2000 mori 1,Am.J.Clin Nutr 2000 cited by examiner
2. year 2006 mori 2,Curr.Opinion Clin. cited by examiner
Nutr.Metab.care 2006
3. year 2003 mori volume 35,No. 7, cited by others
pp 772-781, DHA and EPA
Hypertensive TYPE 2 Diabetic
subjects
4. year 1999 mori DHA but not EPA, cited by others
Hypertension
PATENTS 8357677,8318715,8367652,8431560,8518929
1. year 2000 mori Same as above cited by applicant
2. year 2006 mori Same as above cited by applicant
3. year 2003 mori Same as above cited by applicant
4. year 1999 mori Same as above cited by applicant
Please note: I believe that you citing ( Mori paper year 2002, Am J Clin Nutr 2002; 76:1007-15 ) is the same as documented as Mori volume 35,No.7, pp772-782,DHA and EPA Hypertensive Type 2 Diabetics Subjects.
Legal minds on this board.... since these Mori papers are cited in the Patents can't SINGER somehow bring them out in the Appellant Court
Case, refuting Judge Du's opinions concerning Mori. This information would not be considered new to the District Court's briefs and final ruling.
OBVIOUSNESS
It can be assumed that in MORI that ldl raised up by 3.5% using EPA which was not stag significant, but all studies prior reflected increased ldl the higher your tri's increased... since all studies prior were for tri's lower than 500 and LOVAZA was for TRI'S over 500 that increased ldl and people with tri's over 500 had genentic problems ...how could you ANTICIPATE that pure EPA would NOT increase LDL.... YOU would assume as SINGER points out that Judge Du's ASSUMPTIONS are nor clear...
Question for lawyers on this board.... someone please comment that has legal expertise...
I have read the opening briefs twice and the following leads to me asking this question:
Through out the brief Singer always refers to "Skilled Artisan "
when talking about Obviousness whether in Primi Facia or Secondary
Considerations. He does not refer to Posa (person of ordinary skill)
until end of brief. There is quite a difference between what a Skilled
Artisan would see/understand than a Person Of Ordinary Skill would
see/understand. Only on page #58 he refers to "Ordinary Artisan" and
page #59 "Ordinary Skill" does he refer to POSA.
Is Singer trying to make his argument more emphatic by making the Appellant Court understand that scientists of skill could not see Obviouness, let alone those of ordinary skill.... or is he required to use Skilled Artisan when referring to scientists working on studies, new drugs ,etc.
JL
Submitting an AMICUS BRIEF would be so easy with your daughter's help.... like your band of brothers at INSG, why not support your brothers... your medical expertise concerning high Trig's to LDL would capture the Appellant Court attention...
JL
Have that AMICUS BRIEF ready to support AMARIN ???
Question for lawyers on this board.... someone please comment that has legal expertise...
I have read the opening briefs twice and the following leads to me asking this question:
Through out the brief Singer always refers to "Skilled Artisan "
when talking about Obviousness whether in Primi Facia or Secondary
Considerations. He does not refer to Posa (person of ordinary skill)
until end of brief. There is quite a difference between what a Skilled
Artisan would see/understand than a Person Of Ordinary Skill would
see/understand. Only on page #58 he refers to "Ordinary Artisan" and
page #59 "Ordinary Skill" does he refer to POSA.
Is Singer trying to make his argument more emphatic by making the Appellant Court understand that scientists of skill could not see Obviouness, let alone those of ordinary skill.... or is he required to use Skilled Artisan when referring to scientists working on studies, new drugs ,etc.
baker bros.
02-14-20 shares 34,620,957 vs 05-15-20 34,496,685 shares equals .00356 % net lower change or virtually no change.... total ownwership in AMARIN goes from 49.5% to 51.5 % institutional holdings...AS OF 05-15-2020
JL
So far you have not committed to writing an AMICUS BRIEF to support Amarin...you have posted 10978 times on this board mostly about your medical knowledge... now you have a chance to show this board your full support, and have a daughter that can help you in this endeavor...WHY are you not responding when Amarin needs you the most ??????
JL
Your daughter is a lawyer and understands patent law.... please file an AMICUS BRIEF in support of Amarin to the Appellant Court concerning the correlation of high trig's to ldl... She should be able to write and effective summary with your help...
To the board...
I have often referred to Occam's Razor ( a set of complicated explanations of an event the simplest explanation is best).....
IMO, Judge Du's ruling could be explained with this narrative... before and during the trial, the case presented and the motions presented were ruled on, keeping the facts presented within rules of law....
The ruling itself, leads one to believe that she is a liberal, activist judge looking to benefit individuals at the expense of corporations success...
1. The trial ends late January, 2020.... nothing out of place
concerning her leaning to Amarin or Generics..
2. Post trial documents and summaries due from Amarin and Defendants
before end of Feb. 2020
3. She is given promotion during Jan/Feb to Chief Justice of Nevada
District Court.... thus in charge of assigning all judges,
assistants, etc. to each court at her discretion... takes up a great
amount of time..
4. She gives Ms. Peggy Vannozzi ( COURT ADMINISTRATOR ) and her lead
Law Clerk ( see my i-hub post 263180 ) her overview and instructions
of how to write the ruling with the outcome so desired...
5. All of a sudden a PLAGUE now known as COVERT 19 hits the UNITED
STATES and the WORLD... in MARCH 2020... the world stands still,
confusion rains down... everything is shut down .... the courts stay
open , but she must come up with how all the Nevada courts will
function and who works and who gets furloughed, and who gets laid
off..
6. Peggy Vannossi writes a ruling without MEDICAL EXPERTISE, or
knowlege of Patent ( USPTO ) workings or background of
medical studies, thus rules of law ,etc. are not met.... Judge Du's
fails to really put the time in her review and she signs the RULING
off...because her time is more valuable elsewhere...
She may regret what comes next from the APPELLANT COURT...
JL...
Why not send an AMICUS Brief to the Appellant Court in support of Amarin concerning the Friedwald Equation ( tri's correlation to ldl )
CaptBeer..
This would be a very appropriate time for JL to show his support of AMARIN...especially since his expertise is in science....and this information would be very positive to explain Tri's relationship to LDL
How about it JL....
sorry , I meant "notice of docketing"
RAF
Has PACER posted Amarin's " notice of documents " for the upcoming appellate court case...
Quick question to the board.....
Generally oral arguments are intrical to court cases.... Sometime during the case, Judge Du stipulated no oral arguments would be presented... WHO requested no oral arguments ... the Plaintiffs/the Defendants or did Judge Du make that decision herself.... normally oral arguments provide some fluidity between the parties and the judge concerning points of law, concerns of explanations of raised questions, or other considerations some party might need explanation of, etc. ... oral arguments present a glimpse of how judge may be leaning.... lack of oral arguments seems questionable, and allowed her to be predisposed...
Can anyone answer this question : Why no oral arguments
HDG
BB would have to sold out on 03-31-2020 at $4.oo-$4.50 per share and will be posted before 05-15-2020... or they sold out during the following days at a lower price of $5.25....
These preferred shares are 10 for 1 ADS with a conversion price....
May 15 should be interesting..
Mateo
Yes you are stupid.. plain as day
We have to get approval first to market in the EU, which will be 3rd/4th quarter 2020.... per the CC, JT is talking to many parties whether to GIA/PARTNER... He is already making plans either way....
READ this text again .... your head must be in the clouds or buried in the ground...
Whal
Your words "preserve value " covers what happens next... If JT goes GIA and we are successful in litigation with a reversal, then JT can still sell the company as a whole. IF JT goes GIA and we lose appeal then we still a company that can sell EU and ROW. If we partner and win then a BP only gets USA with royalties. If we lose then we are a Royalty Company only...
JT wants early expedited court action, but if court's decision goes into next year, then he has no option, but to initiate EU sales before end of 2020.
get your obscene right...
let's see
1. AMARIN APPROVAL from FDA Dec. 19,2019
2. AMARIN submits to EU in Jan. 2020
3. AMARIN receives 120 day letter from EU in late March 2020.
4. Amarin responds to EU early MAY 2020
5. AMARIN will receive response from EU July/ AUGUST 2020
6. AMARIN may have to respond to minor inquiry again from EU, or could be clear to go.
7. AMARIN could get approval from EU Sept/Oct, 2020
So what are you complaining about or do you just like to complain????
whal...OMG.... you're such... a DIVA
The board doesn't need your constant negative views over and over again!!!!
Whal
Please show us any documentation to how you arrived that GENERICS now have an API from NIPPON SUISAN..... that article was posted in DEC. 2018...
NIPPON works together with MOCHIDA and AMARIN....
You're making up complete false information to this board.... again anything that can be negative as usual....
Updating:
1. Amarin's upcoming CC has not been posted ... hopefully it will be on May 5,2020.... that would be the same day that Amarin files it's " notice of docketing " to the court concerning the APPEAL.... JT could present it somehow during the CC and answer questions from the analysts...
2. Zumantu's posting #268268 about patent for 96-98% pure EPA. Nippon is a manufacturer ( API supplier ) for Mochida and Amarin.... both Amarin and Mochida entered into agreements in 2019 concerning collaborations of multiple areas of treatment , uses, encapsulations , sales, etc.
3. short interest will be back up for period ending 04-15-2020 somewhere about 48m....
JL
By the way selling a hedge is not selling shares, but by buying puts or selling calls or short trading.... you just sold Amarin Corp shares...
whal
Only you would back him .... you have always been a negative contrarian poster... look at your litany of postings.. every thing I stated about JL is in his postings... no wonder HDG has both of you on ignore...
Please if someone can respond !!!
Whoever posted the April 17, 2020 MARKMAN ADVISORS post that HAMOA responded to ...could you post it again on this board.... somehow the original post has been removed... trying to review it to MARKMAN blog posted MARCH 30, 2020
Hamoa ...
Can you post the MARKMAN ADVISORS blog dated April 17, 2020, if you know how to retrieve it.... it has been removed from this board after it was posted on APRIL 17....
invest...
Hdg gone until approx.MAY 1.... What did I miss... what is he doing... why will he be gone
What value are you top this board?????
JT in effect stated he would be keeping the 8oo sales rep's on Monday... plain and simple .... nowhere did he state he would release any of them...
I printed your exact words.... that post of yours was not an opinion.... you stated they would announce laying off rep's on MONDAY....
You can't even own up to your own words....
whal
whal this is your post #264513.... word for word
Con: The new hires will not pay for themselves...
Expect a cut back on new hires with the CC " ON MONDAY "
If not.... please post the Uwere right and I was wrong...
What part of this do you not understand.... you have been and always will be a negative poster....
Whal
Please review this post #264513.... answer any way you see fit.... your contrarian posts ( negative posts ) are constant and still serve no purpose...
Some states, yes tier 3 but still a non preferred drug ....as of MARCH 1, 2020 the last time I checked....
That's where yours is right now...
Remember your post #264360 care to comment????
Are your bags brown or black....
Please note Humana and UNITED HEALTH CARE are still tier 4.... hoping they get a 6 month review or AMARIN has to wait for year end review.....
dmiller...
That's because that is where yous is right now....
Remember your post #264360..... look at it again..... your bags are on the front porch.... I'll help load
postes
I thought you had packed your bags by now.....